Posted on March 20th, 2013 by Logan Lafferty
Differential diagnosis of dementia in patients with equivocal clinical presentations may be sharpened with an imaging technique recently approved for other purposes, a researcher said here. SPECT imaging with a radioactive iodine-based tracer -- sold under the name DaTscan -- distinguished patients with Lewy body dementia and non-amnestic mild cognitive impairment (MCI) from those with Alzheimer's disease and amnestic MCI in a pilot study, said Bradley Boeve, MD, of the Mayo Clinic in Rochester, Minn.
MedPage Today by John Gever
Tags: alzheimer's disease, DaTscan, dementia, Dr. Bradley Boeve, imaging technique, Lewy Body Dementia, Mayo Clinic Rochester, MedPage Today, mild cognitive impairment, Neurology, Research, SPECT imaging, Technology
You must be logged-in to the site to post a comment.